H1 2025 results now out
Read moreAlzheimer peptide vaccine: Testimonial with Tord Labuda, CEO, Alzinova AB
Learn more about the collaboration
Watch the video hereInnovation for large-scale peptide production
See our presentation at a recent broker event related to GLP-1
Download presentationCreating the future in peptides
We lead innovation in peptide API’s to the benefit of millions of patients
Contact usAhead on green peptide chemistry
Together we improve process performance while reducing the environmental footprint
Learn moreMarket leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
Alzinova testimonial: Alzheimer’s peptide vaccine with PolyPeptide
1 Sep 2025 - September is International Alzheimer’s Month, a reminder of the urgent need to advance research and treatment options for patients and families affected worldwide. It is an […]
Read moreBackbone Protecting Groups for Enhanced Peptide and Protein Synthesis
13 Aug 2025 - This review provides a comprehensive account of the use of backbone N-protecting groups in peptide synthesis. It includes detailed synthetic methods relating to their introduction and removal […]
Read more